×

本司产品仅用于科研,不用于临床诊断和治疗

全国免费热线:400-999-2100

您身边的细胞培养专家!

所有分类
  • 所有分类
  • 细胞系
  • 原代细胞
  • 血清
  • 细胞培养基
  • 辅助试剂
  • 细胞凋亡检测试剂盒
  • 细胞房除菌产品
热搜: 胎牛血清 VERO RAW264.7 成纤维细胞 间充质干细胞 上皮细胞

忘记密码

个人邮箱:
验证码: captcha

账号激活

个人邮箱:
×
当前位置:首页 >> 产品中心 >> 细胞资源库 >> 细胞系 >> 小鼠

产品中心Cell Resources

联系我们CONTACT US

  • Renca [RenCa] (小鼠肾癌细胞) (STR鉴定正确)
  • Renca [RenCa] (小鼠肾癌细胞) (STR鉴定正确)
  • Renca [RenCa] (小鼠肾癌细胞) (STR鉴定正确)
  • Renca [RenCa] (小鼠肾癌细胞) (STR鉴定正确)
  • Renca [RenCa] (小鼠肾癌细胞) (STR鉴定正确)
  • Renca [RenCa] (小鼠肾癌细胞) (STR鉴定正确)
  • Renca [RenCa] (小鼠肾癌细胞) (STR鉴定正确)

Renca [RenCa] (小鼠肾癌细胞) (STR鉴定正确)

货号:CL-0568

规格:1×10⁶cells/T25培养瓶

价格: ¥1600

生长培养基:RPMI-164010% FBS1% P/S0.1mM NEAA1mM Sodium Pyruvate2mM L-glutamine

数量: - +

  • Renca [RenCa] (小鼠肾癌细胞) (STR鉴定正确)
  • Renca [RenCa] (小鼠肾癌细胞) (STR鉴定正确)
  • Renca [RenCa] (小鼠肾癌细胞) (STR鉴定正确)
  • Renca [RenCa] (小鼠肾癌细胞) (STR鉴定正确)
  • Renca [RenCa] (小鼠肾癌细胞) (STR鉴定正确)
  • Renca [RenCa] (小鼠肾癌细胞) (STR鉴定正确)
  • Renca [RenCa] (小鼠肾癌细胞) (STR鉴定正确)

推荐搭配

套餐1:

Renca [RenCa] (小鼠肾癌细胞) (STR鉴定正确) ¥1600

细胞培养最优解!

套餐组合价:¥2050¥2150

加入购物车

搭配套餐已成功加入购物车!

产品概述
产品信息
名称 Renca [RenCa] (小鼠肾癌细胞) (STR鉴定正确)
别称 Renca; RENCA; Renal Carcinoma
种属 小鼠
生长特性 贴壁细胞
细胞形态 上皮细胞样
冻存条件 冻存液:55% 基础培养基+40%FBS+5%DMSO 温度:液氮
培养方案A(默认)
培养条件:
气相:空气,95%;CO2,5%, 温度:37℃
推荐传代比例 1:3-1:6
推荐换液频率 2-3次/周
注意事项 对血清敏感,血清质量对细胞形态影响较大
参考资料(来源文献)
年龄(性别) 雄性;6周龄
组织来源 肾脏
细胞类型 肿瘤细胞
肿瘤类型 肾癌细胞
生物安全等级 BSL-1
保藏机构 ATCC; CRL-2947
STR鉴定
  • STR位点信息
    18-3 18,20
    6-7 12
    5-5 14,15
    X-1 25
    1-2 16,18
    7-1 24.2,25.2,26.2
    8-1 13
    1-1 16,17,18
    19-2 13,14
    15-3 22.3,23.3
    12-1 16
    6-4 18,19
    4-2 21.3
    3-2 14,15
    2-1 15,16,17
    13-1

    16.2,17.2

    11-2 17,18
    17-2 15,17
  • STR鉴定图
参考文献
文献列表
  • Bispecific fibrous glue synergistically boosts vascular normalization and antitumor immunity for advanced renal carcinoma therapy (2024-03-28)

    作者:Xiu-Hai Wu:1.Department of Urology, Harbin Medical University Cancer Hospital, Harbin, 150081, China; CAS Center for Excellence in Nanoscience, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology (NCNST) No. 11 Beiyitiao, Zhongguancun, Beijing, 100190, China; NHC Key Laboratory of Molecular Probes and Targeted Diagnosis and Therapy, Harbin Medical University, Harbin, 150001, China. ; Jia-Qi Wang:1.Department of Urology, Harbin Medical University Cancer Hospital, Harbin, 150081, China; CAS Center for Excellence in Nanoscience, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology (NCNST) No. 11 Beiyitiao, Zhongguancun, Beijing, 100190, China. ; Man-Di Wang:1.CAS Center for Excellence in Nanoscience, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, National Center for Nanoscience and Technology (NCNST) No. 11 Beiyitiao, Zhon

    期刊:Bispecific fibrous glue synergistically boosts vascular normalization and antitumor immunity for advanced renal carcinoma therapy

    DOI:10.1016/j.biomaterials.2024.122550

    影响因子 :14.0

    引用产品: Renca [RenCa] 细胞 ,  293T [HEK-293T] 细胞

  • A novel mitochondria-targeting DHODH inhibitor induces robust ferroptosis and alleviates immune suppression (2024-02-27)

    作者:Yongrui Hai:1.Institute of Medical Research, Northwestern Polytechnical University, Xi'an 710072, China; Research & Development Institute of Northwestern Polytechnical University in Shenzhen, 518057, China. ; Renming Fan:1.Institute of Medical Research, Northwestern Polytechnical University, Xi'an 710072, China; Research & Development Institute of Northwestern Polytechnical University in Shenzhen, 518057, China. ; Ting Zhao:1.School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang 110016, China. ; Ruizhuo Lin:1.Institute of Medical Research, Northwestern Polytechnical University, Xi'an 710072, China; Research & Development Institute of Northwestern Polytechnical University in Shenzhen, 518057, China. ; Junyan Zhuang:1.Institute of Medical Research, Northwestern Polytechnical University, Xi'an 710072, China; Research & Development Institute of Northwestern Polytechnical University in Shenzhen, 518057, China. ; Aohua Deng:1.Institute of Medical Research, N

    期刊:A novel mitochondria-targeting DHODH inhibitor induces robust ferroptosis and alleviates immune suppression

    DOI:10.1016/j.phrs.2024.107115

    影响因子 :9.3

    引用产品: B16-F10 细胞 ,  A-375 细胞 ,  4T1 细胞 ,  Renca [RenCa] 细胞 ,  GL261 细胞 ,  U-87 MG 细胞 ,  SH-SY5Y [SHSY-5Y] 细胞 ,  U251 细胞

  • Therapeutic effects and underlying mechanism of poly (L-glutamic acid)-g-methoxy poly (ethylene glycol)/combretastatin A4/BLZ945 nanoparticles on Renca renal carcinoma (2024-02-05)

    作者:Jiaqi Chen:1.Department of Nephrology, China-Japan Union Hospital of Jilin University, Jilin University, Changchun, China. ; Min Yin:1.Department of Nephrology, China-Japan Union Hospital of Jilin University, Jilin University, Changchun, China. ; Chenguang Yang:1.Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, China. ; Kun Wang:1.Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, China. ; Lili Ma:1.Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, China. ; Haiyang Yu:1.Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, China. ; Yue Huang:1.Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, China. ; Feng Liu:1.Department of Nep

    期刊:Therapeutic effects and underlying mechanism of poly (L-glutamic acid)-g-methoxy poly (ethylene glycol)/combretastatin A4/BLZ945 nanoparticles on Renca renal carcinoma

    DOI:10.3389/fbioe.2024.1336692

    影响因子 :5.7

    引用产品: Renca [RenCa] 细胞

  • Metabolic classifications of renal cell carcinoma reveal intrinsic connections with clinical and immune characteristics (2023-02-24)

    作者:Le Li:1.Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, No.1095, Jiefang Rd, Wuhan, China. ; Zheng Chao:1.Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, No.1095, Jiefang Rd, Wuhan, China. ; Un Waikeong:1.Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, No.1095, Jiefang Rd, Wuhan, China. ; Jun Xiao:1.Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, No.1095, Jiefang Rd, Wuhan, China. ; Yue Ge:1.Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, No.1095, Jiefang Rd, Wuhan, China. ; Yanan Wang:1.Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, No.1095, Jiefang Rd, Wuhan, China. ; Zezhong Xiong:1.Department of Urology,

    期刊:Metabolic classifications of renal cell carcinoma reveal intrinsic connections with clinical and immune characteristics

    DOI:10.1186/s12967-023-03978-y

    影响因子 :7.4

    引用产品: Renca [RenCa] 细胞

  • Total Flavone Content of Cydonia oblonga Miller Inhibits Proliferation and Migration of Renal Carcinoma Cells by Inhibiting the S1PR2/FAK Pathway (2023-03-30)

    作者:Department of Pharmacology, School of Pharmacy, Xinjiang Medical University, No. 393, Xinyi Road, Urumqi 830011, Xinjiang, China; Department of Pharmacology, School of Basic Medical Sciences, Health Science Center, Peking University, Beijing 100191, China

    期刊:Total Flavone Content of Cydonia oblonga Miller Inhibits Proliferation and Migration of Renal Carcinoma Cells by Inhibiting the S1PR2/FAK Pathway

    DOI:10.1155/2023/8890518

    影响因子 :4.0

    引用产品: 786-O [786-0] 细胞 ,  Renca [RenCa] 细胞 ,  Renca [RenCa]细胞专用培养基

  • RRM2 Regulates Sensitivity to Sunitinib and PD-1 Blockade in Renal Cancer by Stabilizing ANXA1 and Activating the AKT Pathway (2007-01-20)

    作者:Wei Xiong:1.Department of Urology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, 410011, China. ; 2.Uro-Oncology Institute of Central South University, Changsha, Hunan, 410011, China. ; Bin Zhang:1.Cancer center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China. ; Haixin Yu:1.Cancer center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China. ; Liang Zhu:1.Department of Urology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, 410011, China. ; 2.Uro-Oncology Institute of Central South University, Changsha, Hunan, 410011, China. ; Lu Yi:1.Department of Urology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, 410011, China. ; 2.Uro-Oncology Institute of Central South University, Changsha, Hunan, 410011, China. ; Xin Jin:1.Department of Urology, The Second Xiangya Hospital, Central South University,

    期刊:RRM2 Regulates Sensitivity to Sunitinib and PD-1 Blockade in Renal Cancer by Stabilizing ANXA1 and Activating the AKT Pathway

    DOI:10.1002/advs.202100881

    影响因子 :15.1

    引用产品: 786-O [786-0] 细胞 ,  A-498 细胞 ,  Renca [RenCa] 细胞 ,  特级胎牛血清 ,  青霉素-链霉素溶液 (双抗),100× ,  MEM (含NEAA) 培养基 ,  Renca [RenCa]细胞专用培养基

  • 点击展开收起列表
FAQs

Q:{{item.question}}

A:

暂无数据
产品资料
注:百度浏览器无法支持扫一扫功能,请输入识别码,获取相应产品资料

识别码示意图

确定
邱国娜/胡文君

邱国娜/胡文君

【 上海 】

何帆

何帆

【 陕西、甘肃、宁夏、青海、新疆 】

 熊经理

熊经理

【 海南 】

朱莎莉

朱莎莉

【 湖北 】

刘本佳

刘本佳

【江苏(除南京外)】

章臣雄

章臣雄

【 广州 】

杜焱炜

杜焱炜

【 四川、云南、西藏 】

田博浩

田博浩

【 重庆、贵州 】

石文平

石文平

【 北京、辽宁 】

胡文君

胡文君

【江西】

李荣枫

李荣枫

【 天津、河北、内蒙古、山西 】

陈雨兰

陈雨兰

【 山东 】

尹国文

尹国文

【浙江】

唐小花

唐小花

【 吉林、黑龙江 】

付帅

付帅

【 安徽 】

朱俊宇

朱俊宇

【 河南、广西 】

李庆祖

李庆祖

【 湖南 】

熊志亮

熊志亮

【 深圳 】

梅文强

梅文强

【福建】

林钊光

林钊光

【南京】

微信扫一扫咨询

微信扫一扫咨询

在线客服
关闭
在线咨询

关注微信公众号